Welcome to ZisNews!

Read your favorite news, except the excluded topics, by you. Register
No overlapping ads for registered users

Govt to amend rules for speedy approvals for medical devices

Posted on: Jun 29, 2026 04:42 IST | Posted by: Hindustantimes
Govt to amend rules for speedy approvals for medical devices
THe unification ministry of wellness and fellowship welfare has proposed amendments to medical gimmick rules to fast-track licensing approvals for moderate- to high-risk medical devices, according to people familiar spirit with the matter.“The ministry of health and family welfare has published a draft notification in the Official Gazette proposing amendments to the Medical Devices Rules, 2017, with the objective of simplifying and expediting the licensing process for medical devices while ensuring continued compliance with quality, safety and performance requirements,” read the health ministry statement.The draft notification was issued based on the suggestions made by the Drugs and Technical Advisory Board (DTAB) after a detailed consultation.According to the health ministry, the proposed amendments seek to rationalise the timelines for the grant of manufacturing licences for medical devices across different risk categories. The initiative is also aimed at enhancing the ease of doing business, improving regulatory efficiency, and facilitating the timely availability of quality medical devices in the country.Under the Medical Devices Rules, 2017, medical devices are classified into four risk-based categories—Class A, Class B, Class C and Class D—with Class D comprising the highest-risk devices.The Rules prescribe statutory timelines for processing manufacturers’ applications for the grant of manufacturing licences in each category. The proposed amendments seek to reduce these timelines, thereby enabling faster regulatory approvals while maintaining established standards of quality, safety and performance, the statement said.For Class B medical devices, which include low- to moderate-risk devices such as blood pressure monitors, hypodermic needles and pulse oximeters, the timeline for grant of manufacturing licence has been proposed to be reduced from 140 days to 115 days.Similarly, for Class C and Class D medical devices, which include high-risk devices such as cardiac stents, hip and knee implants, and other orthopaedic implants, the timeline for granting a manufacturing licence has been proposed to be reduced from 105 days to 90 days.For Class A devices, which include low-risk items such as medical thermometers and stethoscopes, there has been no change.The draft amendments also introduce clearly defined timelines for each stage of the licensing process, including scrutiny of applications, audit by notified bodies, verification of compliance and issuance of licences.According to the draft notification, the applicant’s manufacturing site of the applicant will conform to the requirements for quality management system and will be verified through an audit by a notified body before the license is granted. The State Licensing Authority will ensure that a registered notified body carries out the site audit and duly submits the audit report to the State Licensing Authority.“This is expected to bring greater transparency, predictability and efficiency to the regulatory framework, benefiting both the medical device industry and patients through faster access to quality-assured medical devices,” read the health ministry statement.The draft notification has been placed in the public domain for comments and suggestions from all stakeholders. The final notification will be published in the Gazette of India after reviewing the comments and suggestions.

Global News Perspectives

In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.

Customizable News Feed

At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.

Like or Comment on News

Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.

Download the Android App

For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.

Diverse News Categories

With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.

Login to Like (0) Login to Dislike (0)

Login to comment.

No comments yet.